To unveil novel genetic mechanisms that may support tumor aggressiveness, we focused on the ‘quadruple WT’ case subgroup, which is devoid of mutations in the RAS/phosphoinositide 3‐kinase (PI3K) pathway, and where correlations between oncogenic pathways and mechanisms of tumor progression are partly obscure [5, 6, 7]. Here, PIK3CA is linked to neoplasm.